Caroline Hammer
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
Papers in
-
- Lipid Membrane Structure and Behavior 3
- Glycosylation and Glycoproteins Research 1
- Oncology 4
- Drug Transport and Resistance Mechanisms 1
- Co-authors
- Ernst R. Waelti (3 shared papers)Hans‐Peter Marti (2 shared papers)Jörg Huwyler (2 shared papers)Gérald Tuffin (2 shared papers)Alessandro Lugli (3 shared papers)Inti Zlobec (3 shared papers)Viktor H. Koelzer (2 shared papers)Heather Dawson (2 shared papers)
- Journals
- Journal of drug targeting (2 papers)Journal of Clinical Oncology (1 paper)Journal of the Royal Society of Medicine (1 paper)Critical Care (1 paper)Histopathology (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Caroline Hammer
16 papers receiving 352 citations
Peers
Comparison fields: 5 of 71
- Oncology 149
- Nephrology 26
- Cancer Research 44
- Biomaterials 41
- Pathology and Forensic Medicine 42
Countries citing papers authored by Caroline Hammer
This map shows the geographic impact of Caroline Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Hammer more than expected).
Fields of papers citing papers by Caroline Hammer
This network shows the impact of papers produced by Caroline Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Hammer. The network helps show where Caroline Hammer may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline Hammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 80 | |
| 2 | 2005 | 64 | |
| 3 | 2013 | 52 | |
| 4 | 2013 | 47 | |
| 5 | 2007 | 26 | |
| 6 | 2011 | 18 | |
| 7 | 2016 | 16 | |
| 8 | 1982 | 10 | |
| 9 | 2008 | 9 | |
| 10 | 1980 | 9 | |
| 11 | 2012 | 7 | |
| 12 | 2017 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 3 | |
| 15 | 2017 | 2 | |
| 16 | 2015 | 1 |
About Caroline Hammer
Caroline Hammer is a scholar working on Molecular Biology, Oncology, Epidemiology, Biomaterials and Immunology, having authored 16 papers that have together received 356 indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Sepsis Diagnosis and Treatment (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Inflammation biomarkers and pathways (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Oncology (149 citations), Nephrology (26 citations), Cancer Research (44 citations), Biomaterials (41 citations) and Pathology and Forensic Medicine (42 citations). Caroline Hammer has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Ernst R. Waelti, Hans‐Peter Marti, Jörg Huwyler, Gérald Tuffin, Alessandro Lugli, Inti Zlobec, Viktor H. Koelzer, Heather Dawson, Mary Economou and Eva Karamitopoulou. Their work appears in journals such as Journal of drug targeting, Journal of Clinical Oncology, Journal of the Royal Society of Medicine, Critical Care and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.